Clinical trial
SubQStim Pivotal Study: A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Nerve Stimulation. Protocol 1666
NCT01818297 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SubQStim Pivotal Study: A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Nerve Stimulation. Protocol 1666
- Lead sponsor
- MedtronicNeuro
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2013
- Completion date
- March 31, 2016
- Enrollment
- 137 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
failed back surgery syndrome, post-laminectomy syndrome